The purpose of the Histopathology and Experimental Animal Facility is to provide the following services in support of by the scientific needs of members of the KCCC: (1) Specialized facilities (e.g., segregated housing, exhaust/containment systems) and specialized animals care, as well as expertise in experimental design and conduct and expert technical assistance for the following types of experiments: animal studies with delivery to wide range of animal species of carcinogenic/toxic chemicals, infectious agents (e.g., challenge experiments), intervention compounds (e.g., chemoprevention or anti- cancer drugs), using inhalation, parenteral, dermal and oral administration routes of exposure. (2) Segregated housing and health monitoring of animals that do not yet have a proven VAF status or that carry transplantable tumors that have not yet been MAP tested; work with these types of animals is not possible in the Centralized Animal Facility. (3) Necropsy services including appropriate tissue fixation required for these animal experiments. (4) High quality histology services geared towards the experimental needs of KCCC members, including: paraffin processing and slide preparation, cryostat sectioning, preparation of slides for immunohistochemistry and in situ hybridization and PCR, plastic embedding and slide preparation, routine conventional and (immuno)histochemical staining, capability to apply special non-routine staining procedures. (5) Basic scanning electron microscopy (sample preparation and microscopy), transmission and electron microscopy (sample preparation only), and morphometry (stereology) services. And (6) Comprehensive consultation and collaboration on carcinogen administration to laboratory animals and experimental pathology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016087-21
Application #
6101774
Study Section
Project Start
1999-05-10
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
21
Fiscal Year
1999
Total Cost
Indirect Cost
Name
New York University
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016
Snetkova, Valentina; Skok, Jane A (2018) Enhancer talk. Epigenomics 10:483-498
Litwinoff, Evelyn M S; Gold, Merav Y; Singh, Karan et al. (2018) Myeloid ATG16L1 does not affect adipose tissue inflammation or body mass in mice fed high fat diet. Obes Res Clin Pract 12:174-186
Lee, Chul-Hwan; Holder, Marlene; Grau, Daniel et al. (2018) Distinct Stimulatory Mechanisms Regulate the Catalytic Activity of Polycomb Repressive Complex 2. Mol Cell 70:435-448.e5
Fan, Xiaozhou; Alekseyenko, Alexander V; Wu, Jing et al. (2018) Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut 67:120-127
Gregory, Ann C; Sullivan, Matthew B; Segal, Leopoldo N et al. (2018) Smoking is associated with quantifiable differences in the human lung DNA virome and metabolome. Respir Res 19:174
Taylor, Martin S; Altukhov, Ilya; Molloy, Kelly R et al. (2018) Dissection of affinity captured LINE-1 macromolecular complexes. Elife 7:
Bertrand, Anne; Baron, Maria; Hoang, Dung M et al. (2018) In Vivo Evaluation of Neuronal Transport in Murine Models of Neurodegeneration Using Manganese-Enhanced MRI. Methods Mol Biol 1779:527-541
Jung, Seungyoun; Allen, Naomi; Arslan, Alan A et al. (2018) Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts. Int J Cancer 142:262-270
Wang, Sophia S; Carrington, Mary; Berndt, Sonja I et al. (2018) HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res 78:4086-4096
Kirkling, Margaret E; Cytlak, Urszula; Lau, Colleen M et al. (2018) Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells. Cell Rep 23:3658-3672.e6

Showing the most recent 10 out of 1170 publications